Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins / linezolid attending: chief complaint: - neurological deficits described as "spinning" while at acute rehab. - originally had right innominate artery aneurysm which was repaired with left carotid to aortic innominate artery bypass , c/b respiratory failure and pea arrest. major surgical or invasive procedure: on this hospital stay: 1. right vats and thoracic duct ligation 2. thoracic duct embolization and talc pleurodesis 3. tracheostomy and percutaneous endoscopic gastrostomy 4. exploratory laparotomy, pancreatic necrosectomy, gastrostomy tube 5. exploratory laparotomy, abdominal wash out 6. exploratory lap, takedown gastrostomy, debride necrotic pancreas and multiple retroperitoneal abscesses 7. abdominal closure and vac dressing application 8. left thoracotomy and decortication, flexible bronchoscopy on previous hospital stays: 9. aorto innominate and left carotid bypass 10. left carotid to left subclavian bypass using 8 mm ptfe and thoracic aortic stent graft placement history of present illness: 65f c complex medical history, s/p repair of aortic innominate aneurysm (please see list of operative procedures), who returned to from acute rehab with neurological symptoms and found to have numerous problems both related and unrelated to previous operative procedures. past medical history: -- dm2 -- chronic foot ulcers/pvd -- htn -- oa -- obesity -- asthma -- leg pain/neuropathy -- depression -- anemia -- h/o mrsa bacteremia , also septic arthritis treated at . right thalamic hemorrhage resulting in a gait disorder and incontinence of urine, followed by dr. . old cvas. neuropathy, peripheral. anxiety and panic disorder. status post total abdominal hysterectomy. hypercholesterolemia. social history: the patient lives with her daughter and her three kids since being d/c'ed from a nursing home last . has seven children, many grandchildren. smokes to 1 pack per day. family history: brother died of an mi in his 30's, she denies diabetes mellitus in the family. cancer in parents (mother died in 40s, father in 80s), at least two siblings, but unsure what kind. physical exam: on admission: nad, alert rrr, no murmurs decreased bs left hemithorax abd: obese, soft, ? nt, ? nd, unable to auscultate bowel sounds rect: guiac negative, no masses ext: warm and well perfused, + peripheral edema pulse: dp/pt dopplerable bilaterally pertinent results: 03:14pm blood wbc-10.6 rbc-2.52* hgb-7.8* hct-23.0* mcv-91 mch-31.1 mchc-34.1 rdw-16.0* plt ct-68* 03:14pm blood plt ct-68* 03:14pm blood glucose-117* urean-37* creat-1.1 na-137 k-3.3 cl-106 hco3-24 angap-10 03:14pm blood alt-13 ast-27 ld(ldh)-588* alkphos-119* amylase-52 totbili-0.2 03:14pm blood lipase-34 03:14pm blood albumin-1.4* calcium-6.6* phos-3.8 mg-1.7 uricacd-7.1* iron-57 03:14pm blood caltibc-68* ferritn-greater th trf-52* 03:14pm blood tsh-16* 12:15pm pleural triglyc-242 microbiology: time taken not noted log-in date/time: 1:02 am pleural fluid **final report ** gram stain (final ): 1+ (<1 per 1000x field): polymorphonuclear leukocytes. no microorganisms seen. fluid culture (final ): enterobacter cloacae. sparse growth. this organism may develop resistance to third generation cephalosporins during prolonged therapy. therefore, isolates that are initially susceptible may become resistant within three to four days after initiation of therapy. for serious infections, repeat culture and sensitivity testing may therefore be warranted if third generation cephalosporins were used. trimethoprim/sulfa sensitivity testing available on request. proteus species. rare growth. staph aureus coag +. sparse growth. sensitivities performed on culture # 236-6444j . enterococcus sp.. isolated from broth media only, indicating very low numbers of organisms. sensitivities: mic expressed in mcg/ml _________________________________________________________ enterobacter cloacae | enterococcus sp. | | ampicillin------------ =>32 r cefepime-------------- <=1 s ceftazidime----------- =>64 r ceftriaxone----------- =>64 r ciprofloxacin--------- =>4 r gentamicin------------ <=1 s imipenem-------------- <=1 s linezolid------------- 2 s meropenem-------------<=0.25 s penicillin------------ =>64 r piperacillin---------- 32 i tobramycin------------ <=1 s vancomycin------------ =>32 r anaerobic culture (final ): no anaerobes isolated. 5:14 pm urine source: catheter. **final report ** urine culture (final ): proteus mirabilis. >100,000 organisms/ml.. enterobacter cloacae. 10,000-100,000 organisms/ml.. this organism may develop resistance to third generation cephalosporins during prolonged therapy. therefore, isolates that are initially susceptible may become resistant within three to four days after initiation of therapy. for serious infections, repeat culture and sensitivity testing may therefore be warranted if third generation cephalosporins were used. trimethoprim/sulfa sensitivity testing confirmed by . sensitivities: mic expressed in mcg/ml _________________________________________________________ proteus mirabilis | enterobacter cloacae | | ampicillin------------ <=2 s ampicillin/sulbactam-- <=2 s cefazolin------------- <=4 s cefepime-------------- <=1 s <=1 s ceftazidime----------- <=1 s =>64 r ceftriaxone----------- <=1 s =>64 r cefuroxime------------ <=1 s ciprofloxacin--------- 2 i =>4 r gentamicin------------ <=1 s <=1 s imipenem-------------- <=1 s meropenem-------------<=0.25 s <=0.25 s nitrofurantoin-------- 128 r piperacillin---------- <=4 s 32 i piperacillin/tazo----- <=4 s tobramycin------------ <=1 s <=1 s trimethoprim/sulfa---- <=1 s <=1 s 11:52 am blood culture source: line-tunneled cath - no peripheral access. **final report ** aerobic bottle (final ): staph aureus coag +. final sensitivities. oxacillin resistant staphylococci must be reported as also resistant to other penicillins, cephalosporins, carbacephems, carbapenems, and beta-lactamase inhibitor combinations rifampin should not be used alone for therapy. trimethoprim/sulfa sensitivity testing performed by . sensitivities: mic expressed in mcg/ml _________________________________________________________ staph aureus coag + | clindamycin----------- =>8 r erythromycin---------- =>8 r gentamicin------------ <=0.5 s levofloxacin---------- =>8 r oxacillin------------- =>4 r penicillin------------ =>0.5 r rifampin-------------- <=0.5 s tetracycline---------- <=1 s trimethoprim/sulfa---- s vancomycin------------ <=1 s anaerobic bottle (final ): reported by phone to at 0755 on . staph aureus coag +. sensitivities performed from aerobic bottle. 10:47 am sputum source: endotracheal. **final report ** gram stain (final ): >25 pmns and <10 epithelial cells/100x field. 2+ (1-5 per 1000x field): gram positive cocci. in pairs and clusters. 1+ (<1 per 1000x field): gram negative rod(s). respiratory culture (final ): due to mixed bacterial types ( >= 3 colony types) an abbreviated workup will be performed appropriate to the isolates recovered from this site. unable to definitively determine the presence or absence of oropharyngeal flora. unable to r/o pathogens due to overgrowth of swarming proteus spp.. proteus species. moderate growth. staph aureus coag +. moderate growth. oxacillin resistant staphylococci must be reported as also resistant to other penicillins, cephalosporins, carbacephems, carbapenems, and beta-lactamase inhibitor combinations. rifampin should not be used alone for therapy. trimethoprim/sulfa sensitivity testing performed by . gram negative rod(s). sparse growth. of two colonial morphologies. sensitivities: mic expressed in mcg/ml _________________________________________________________ staph aureus coag + | clindamycin----------- =>8 r erythromycin---------- =>8 r gentamicin------------ <=0.5 s levofloxacin---------- =>8 r oxacillin------------- =>4 r penicillin------------ =>0.5 r rifampin-------------- <=0.5 s tetracycline---------- <=1 s trimethoprim/sulfa---- s vancomycin------------ <=1 s 5:08 pm varicella-zoster culture site: back 2 m4 rec'd, also r/o hsv. **final report ** varicella-zoster culture (final ): herpes simplex virus type 2. confirmed by monoclonal fluorescent antibody.. 2:00 pm tissue pancreas. **final report ** gram stain (final ): 1+ (<1 per 1000x field): polymorphonuclear leukocytes. 3+ (5-10 per 1000x field): gram positive cocci. in pairs, chains, and clusters. tissue (final ): reported by phone to cc7c. this is a corrected report (). reported by phone to dr. () . enterococcus sp.. moderate growth. additional sensitivty testing per dr . tigecycline 1.0 mcg/ml (non-suceptible). tigecycline is not approved for testing with resistant enterococci. synercid sensitive by . reported by phone to dr at 10:45am. . previously reported as. sensitive to tigecycline (). daptomycin. 16 mcg/ml (performed at laboratories). staphylococcus, coagulase negative. rare growth. sensitivities: mic expressed in mcg/ml _________________________________________________________ enterococcus sp. | ampicillin------------ =>32 r linezolid------------- 2 s penicillin------------ =>64 r vancomycin------------ =>32 r anaerobic culture (final ): no anaerobes isolated. 7:39 pm stool consistency: soft source: stool. **final report ** clostridium difficile toxin assay (final ): feces negative for c. difficile toxin by eia. (reference range-negative). brief hospital course: neuro: ms. is a woman with a history of right thalamic hemorrhage and left genu/internal capsular lacunar infarcts who is admitted for vascular surgeries and treatment of sepsis on whom we were re-consulted for disconjugate gaze in the setting of sedating medications for intubation. her neuro exam is notable for decreased mental status (following commands only intermittently) although she is arousable by voice and a disconjugate gaze that returns to conjugate midline when she is aroused. certainly, it is reassuring that her gaze corrects itself when she is aroused. she also has all her other brainstem reflexes intact and when aroused she is able to occasionally follow commands. most likely, the intermittent disconjugate gaze (occurring only when she is unconscious) is the result of an encephalopathy. certainly, she has many metabolic reasons to be encephalopathic, as she has bacteremia and pneumonia. however, given her history of intracranial hemorrhage and her maintenance on a heparin gtt (for a history of clotting), we would recommend a low threshold for re-imaging her head. although our suspicion for recurrent intracranial hemorrhage is low, it cannot be fully excluded and she does have risks and a history. ct head : 1. stable appearance of the brain. 2. new air-fluid levels in the sphenoid sinus. the appearance may reflect recent intubation but could be seen in sinusitis, in the appropriate clinical setting. cv: ms. was intermittently on vasopressors throughout her long hospital course, most often for bp support in the setting of sepsis. no evidence of myocardial infarction. most recent echo showed: the left atrium is elongated. left ventricular wall thicknesses are normal. the left ventricular cavity size is normal. overall left ventricular systolic function is mildly depressed with inferior/inferolateral akinesis (lvef= 50%). right ventricular chamber size and free wall motion are normal. the aortic root is mildly dilated at the sinus level. there are three aortic valve leaflets. the aortic valve is not well seen. there is no aortic valve stenosis. the mitral valve leaflets are mildly thickened. mild (1+) mitral regurgitation is seen. the left ventricular inflow pattern suggests impaired relaxation. the estimated pulmonary artery systolic pressure is normal. there is no pericardial effusion. she has been otherwise stable from a cardiovascular standpoint. no apparent difficulty with her vascular repair. pt also has very difficult vascular access with significant thrombosis of upper neck veins, currently with a left ij cvl which has been placed and repositioned multiple times in interventional radiology. the cvl presently infuses but does not aspirate. pulmonary: ms. experienced chylothorax treated with multiple operative procedures (please see operative report list). at present, drainage from the left hemithorax greatly reduced. two chest tubes were removed on date of discharge with one remaining draining to gravity. gi: ms. experience near total pancreatic necrosis of unknown etiology treated with pancreatic debridement and necrosectomy and abdominal drainage (please see operative report list). at present, most recent ct abd/pelvis showed: there is evidence of peripancreatic fat stranding and a small peripancreatic fluid collection measuring 2.9 x 1.2 cm. general surgery consultation deemed that this fluid collection was remarkable but not necessitating intervention. pt was maintained on tube feeds at a stable rate and frequency. heme: ms. has experienced anemia and thrombocytopenia which has necessitated intermittent transfusion of packed rbc and platelets. id: ms. has numerous positive cultures from various sites (please see pertinent lab results for more detail) that have been treated with antibiotics intermittenly per the id consultation service. these infections have manifested with hypothermia and hypotension, sometimes requiring vasopressor support. pt is currently on synercid, meropenem, and caspofungin. antibiotics x 7 days post-discharge with the knowledge that the pt is likley heavily colonized with multiple resistant organisms and may deteriorate without antibiotic support. medications on admission: 1. atorvastatin 20 mg tablet sig: one (1) tablet po daily (daily). 2. citalopram 20 mg tablet sig: one (1) tablet po daily (daily). 3. albuterol 90 mcg/actuation aerosol sig: four (4) puff inhalation q6h (every 6 hours). 4. albuterol sulfate 0.083 % (0.83 mg/ml) solution sig: one (1) inh inhalation q6h (every 6 hours). 5. beclomethasone dipropionate 80 mcg/actuation aerosol sig: one (1) inh inhalation (2 times a day). 6. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). 7. acetaminophen 325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed for pain. 8. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 9. metoprolol tartrate 25 mg tablet sig: 0.5 tablet po bid (2 times a day): hold for sbp < 100 or hr < 60. 10. daptomycin 500 mg recon soln sig: one (1) recon soln intravenous q24h (every 24 hours) for 4 weeks: from / may dc follow labs as on pg 1. 11. insulin sliding scale fingerstick q6h insulin sc sliding scale regular glucose insulin dose 0-60 mg/dl 1 amp d50 61-120 mg/dl 0 units 121-140 mg/dl 2 units 141-160 mg/dl 4 units 161-180 mg/dl 6 units 181-200 mg/dl 8 units 201-220 mg/dl 10 units 221-240 mg/dl 12 units 241-260 mg/dl 14 units 261-280 mg/dl 16 units 281-300 mg/dl 18 units > 300 mg/dl notify m.d. 12. enoxaparin 120 mg/0.8 ml syringe sig: one (1) subcutaneous q12h (every 12 hours) for 7 days: dc when inr is greater then 2/ keep inr . 13. coumadin 5 mg tablet sig: one (1) tablet po at bedtime: inr goal is . discharge medications: 1. med albuterol 0.083% neb soln 1 neb ih q6h:prn @ 2257 2. med aquaphor ointment 1 appl tp tid:prn @ 2257 3. med sarna lotion 1 appl tp tid:prn @ 2257 4. med miconazole powder 2% 1 appl tp tid:prn @ 2257 5. med dextrose 50% 25 gm iv prn glu<55 @ 2257 6. med levothyroxine sodium 25 mcg po/ng daily @ 2257 7. med heparin 5000 unit sc tid @ 2257 8. med quinupristin-dalfopristin 650 mg iv q8h @ 2257 9. med insulin sc (per insulin flowsheet) sliding scale 09/05 @ 2257 10. med meropenem 1000 mg iv q8h @ 2257 11. med hydromorphone (dilaudid) 1 mg iv q4h:prn pain @ 2257 12. med metoclopramide 5 mg po/iv qid:prn @ 0846 13. med ranitidine (liquid) 150 mg po daily @ 0900 14. med albuterol puff ih q4h @ 2148 15. med ipratropium bromide mdi puff ih q4h @ 2148 16. med caspofungin 50 mg iv q24h @ 0937 discharge disposition: extended care facility: & rehab center - discharge diagnosis: 1. peripheral vascular disease 2. chylothorax 3. pancreatic necrosis 4. sepsis 5. upper vein thrombosis 6. diabetes mellitus 7. hypertension 8. copd 9. right thalamic hemorrhage 10. innominate artery aneurysm discharge condition: stable discharge instructions: 1. d/c antibiotics 7 days post discharge. 2. vac dressing change q4days. 3. trach mask as tolerated. followup instructions: 1. follow up with dr. regarding removal of chest tube. procedure: insertion of intercostal catheter for drainage continuous invasive mechanical ventilation for less than 96 consecutive hours venous catheterization, not elsewhere classified parenteral infusion of concentrated nutritional substances other endoscopy of small intestine insertion of endotracheal tube enteral infusion of concentrated nutritional substances other bronchoscopy percutaneous [endoscopic] gastrostomy [peg] cholecystectomy decortication of lung temporary tracheostomy transpleural thoracoscopy injection into thoracic cavity other endovascular procedures on other vessels excision or destruction of lesion or tissue of abdominal wall or umbilicus other excision or destruction of lesion or tissue of pancreas or pancreatic duct other excision or destruction of lesion or tissue of pancreas or pancreatic duct closure of gastrostomy ligation of thoracic duct diagnoses: thrombocytopenia, unspecified anemia, unspecified other postoperative infection unspecified pleural effusion urinary tract infection, site not specified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified unspecified septicemia severe sepsis chronic airway obstruction, not elsewhere classified acute respiratory failure calculus of gallbladder with other cholecystitis, without mention of obstruction cerebral artery occlusion, unspecified with cerebral infarction empyema without mention of fistula acute pancreatitis other retroperitoneal abscess other noninfectious disorders of lymphatic channels 

Answer: The patient is high likely exposed to